Amphera and Alligator Bioscience reveal mitazalimab-MesoPher update
Therapy is being used during pivotal phase 1 study into patients with pancreatic cancer
Read More
Tag: Amphera
Positive results for Amphera’s MesoPher cell therapy
Treatment demonstrated significant survival data in addition to a sustained safety profile
Read More
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
- Alzecure shares new preclinical data on NeuroRestore ACD856 at AD/PD conference
